FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
| Fosgemcitabine palabenamide, 840506-29-8, Fosgemcitabine palabenamide Intermediate 95058-81-4, stock 322.7g, white powder, assay by HPLC 98.9%, HNMR, LCMS we supply. |
| Fosgemcitabine palabenamide, 840506-29-8, Fosgemcitabine palabenamide Intermediate /, stock 571g, white powder, assay by HPLC 98.1%, HNMR, LCMS we supply. |
| Fosgemcitabine palabenamide, 840506-29-8, Fosgemcitabine palabenamide Intermediate 183370-70-9, stock 888.5g, white powder, assay by HPLC 99.8%, HNMR, LCMS we supply. |
| Fosgemcitabine palabenamide, 840506-29-8, Fosgemcitabine palabenamide Intermediate /, stock 280.4g, white powder, assay by HPLC 99.8%, HNMR, LCMS we supply. |
